Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Feb 2024)

Incidental Arrhythmias During Atrial Fibrillation Screening With Repeat 7‐Day Holter ECGs in a Hospital‐Based Patient Population

  • Eleni Goulouti,
  • Anna Lam,
  • Nikolas Nozica,
  • Elena Elchinova,
  • Chrisoula Dernektsi,
  • Felix Neugebauer,
  • Mattia Branca,
  • Helge Servatius,
  • Fabian Noti,
  • Andreas Haeberlin,
  • Gregor Thalmann,
  • Nikola Asenov Kozhuharov,
  • Antonio Madaffari,
  • Hildegard Tanner,
  • Tobias Reichlin,
  • Laurent Roten

DOI
https://doi.org/10.1161/JAHA.123.032223
Journal volume & issue
Vol. 13, no. 4

Abstract

Read online

Background Screening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. The aim of this study was to describe incidental arrhythmias detected during screening for AF in the STAR‐FIB (Predicting SilenT AtRial FIBrillation in Patients at High Thrombembolic Risk) cohort study. Methods and Results In the STAR‐FIB cohort study, we screened hospitalized patients for AF with 3 repeat 7‐day Holter ECGs. We analyzed all Holter ECGs for the presence of the following incidental arrhythmias: (1) sinus node dysfunction, defined as sinus pause of ≥3 seconds’ duration; (2) second‐degree (including Wenckebach) or higher‐degree atrioventricular block (AVB); (3) sustained supraventricular tachycardia of ≥30 seconds’ duration; and (4) sustained ventricular tachycardia of ≥30 seconds’ duration. We furthermore report treatment decisions because of incidental arrhythmias. A total of 2077 Holter ECGs were performed in 794 patients (mean age, 74.7 years; 49% women), resulting in a mean cumulative duration of analyzable ECG signal of 414±136 hours/patient. We found incidental arrhythmias in 94 patients (11.8%). Among these were sinus node dysfunction in 14 patients (1.8%), AVB in 41 (5.2%), supraventricular tachycardia in 42 (5.3%), and ventricular tachycardia in 2 (0.3%). Second‐degree AVB was found in 23 patients (2.9%), 2:1 AVB in 10 (1.3%), and complete AVB in 8 (1%). Subsequently, 8 patients underwent pacemaker implantation, 1 for sinus node dysfunction (post‐AF conversion pause of 9 seconds) and 7 for advanced AVB. One patient had an implantable cardioverter‐defibrillator implanted for syncopal ventricular tachycardia. Conclusions Incidental arrhythmias were frequently detected during screening for AF in the STAR‐FIB study and resulted in device therapy in 1.1% of our cohort patients.

Keywords